Eisai: Lecanemab has been approved in Mexico for the treatment of early Alzheimer's disease.
- Latest
- Detail
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Latest
19:18
According to the HKEX announcement, FOSUN TOURISM Group plans to repurchase shares held by non-controlling Shareholders, and all shares will be canceled in exchange for 7.8 Hong Kong dollars in Cash per planned share.
FOSUN TOURISM0.00%
19:16
Autoliv's new factory in Guangzhou officially opened.
ALV+0.55%
19:13
VOLCAFE predicts that in the 2025/26 Global coffee market, there will be an "unprecedented" fifth consecutive shortage, with a shortfall of 8.5 million bags.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.